RxLogix and FDA Achieve Unprecedented Milestone in Patient Safety Automation

1 Aug 2025

[Aventura, FL] – [8/1/2025] – RxLogix Corporation, a global leader in PV and drug safety solutions, proudly announces a groundbreaking achievement in collaboration with the U.S. Food and Drug Administration (FDA). Together, the teams have reached a significant milestone by successfully implementing a first-of-its-kind capability: running thousands of safety alerts across an entire product dictionary—spanning over 30,000 products—on a weekly basis with unmatched performance and reliability.

This milestone represents a major leap forward for regulatory intelligence and public health. The scale, automation, and precision demonstrated in this project mark a new industry benchmark, transforming the way agencies proactively monitor drug safety signals across vast product portfolios.

“This is a transformative moment not just for RxLogix and the FDA, but for the entire pharmacovigilance community,” said [Raj More], [CEO], RxLogix. “To achieve this level of performance and automation at scale is a testament to the innovation, collaboration, and technical excellence of everyone involved.”

The collaboration showcases RxLogix’s commitment to supporting regulatory agencies with future-ready safety technologies built for real-world performance, rapid scalability, and mission-critical reliability. By enabling faster signal detection and smarter risk mitigation, this achievement underscores the shared mission to protect patients and advance public health outcomes.

RxLogix extends its deepest appreciation to the FDA teams and all stakeholders involved for their unwavering commitment, leadership, and partnership in bringing this bold vision to life.

About RxLogix
RxLogix is a global leader in intelligent Drug Safety solutions, providing next-gen technology and consulting services to life sciences organizations and regulatory agencies. Trusted by top pharmaceutical companies and health authorities worldwide, RxLogix is redefining the future of patient safety through innovation, automation, and insight.

www.rxlogix.com

For media inquiries or more information, contact:
Jeff Tucker
Vice President
jeff.tucker@rxlogix.com